National Center for Advancing Translational Sciences; Notice of Closed Meeting, 3751 [2023-01017]
Download as PDF
Federal Register / Vol. 88, No. 13 / Friday, January 20, 2023 / Notices
Dated: January 13, 2023.
David N. Bochner,
Project Clearance Liaison, National Institute
of General Medical Sciences, National
Institutes of Health.
[FR Doc. 2023–00998 Filed 1–19–23; 8:45 am]
BILLING CODE 4140–01–P
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: January 13, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–01017 Filed 1–19–23; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The cooperative agreement
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the cooperative agreement applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; NCATS CTSA UM1 Review
Special Emphasis Panel.
Date: February 21, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor Henriquez, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892, (301) 435–0813,
henriquv@mail.nih.gov.
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0361.
Project: SAMHSA’s Publications and
Digital Products Website Registration
Surveys (OMB No. 0930–0313)—
Revision
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is requesting OMB approval
for a revision of SAMHSA’s
Publications and Digital Products
website Registration Survey (OMB No.
0930–0313). SAMHSA is authorized
under section 501(d)(16) of the Public
Health Service Act (42 U.S.C.
290aa(d)(16)) to develop and distribute
materials for the prevention, treatment,
and recovery from mental and substance
use disorders. To improve customer
service and lessen the burden on the
public to locate and obtain these
3751
materials, SAMHSA has developed a
website that includes more than 500 free
publications from SAMHSA and its
component Agencies. These products
are available to the public for ordering
and download. When a member of the
public chooses to order hard-copy
publications, it is necessary for
SAMHSA to collect certain customer
information in order to fulfill the
request. To further lessen the burden on
the public and provide the level of
customer service that the public has
come to expect from product websites,
SAMHSA has developed a voluntary
registration process for its publication
website that allows customers to create
accounts. Through these accounts,
SAMHSA customers are able to access
their order histories and save their
shipping addresses. During the website
registration process, SAMHSA will also
ask customers to provide optional
demographic information that helps
SAMHSA to evaluate the use and
distribution of its publications and
improve services to the public.
SAMHSA employs a web-based form
for information collection to avoid
duplication and unnecessary burden on
customers who register for an account.
Customer information is submitted
electronically via web forms on the
samhsa.gov domain. Customers can
submit the web forms at their leisure or
call SAMHSA’s toll-free Call Center and
an information specialist will submit
the forms on their behalf. The electronic
collection of information reduces the
burden on the respondent and
streamlines the data-capturing process.
The following revisions were made to
the SAMHSA Publications and Digital
Products website Registration Survey:
• Revision of the SAMHSA Publications
website Registration Survey Questions
• Addition of a SAMHSA Main Site
Survey version
• Addition of a SAMHSA Store Survey
version
SAMHSA estimates the burden of this
information collection as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN
Annual
frequency
per response
Number of
respondents
lotter on DSK11XQN23PROD with NOTICES1
Website Registration Survey
21,082
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
VerDate Sep<11>2014
17:29 Jan 19, 2023
Jkt 259001
Total annual
responses
1
21,082
Hours per response
.033 (2 min.) .....................................
notice to www.reginfo.gov/public/do/
PRAMain . Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Total hours
696
for Public Comments’’ or by using the
search function.
E:\FR\FM\20JAN1.SGM
20JAN1
Agencies
[Federal Register Volume 88, Number 13 (Friday, January 20, 2023)]
[Notices]
[Page 3751]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01017]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The cooperative agreement applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the cooperative agreement
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; NCATS CTSA UM1 Review Special
Emphasis Panel.
Date: February 21, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, Room 1037,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor Henriquez, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for Advancing
Translational Sciences, National Institutes of Health, 6701
Democracy Boulevard, Room 1037, Bethesda, MD 20892, (301) 435-0813,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: January 13, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-01017 Filed 1-19-23; 8:45 am]
BILLING CODE 4140-01-P